Liquid pharmaceutical composition for the delivery of active ingredients
First Claim
Patent Images
1. A pharmaceutical composition in the form of a suspension comprising a dispersed phase in a liquid continuous phase wherein:
- (a) The dispersed phase comprises solid particles of an active ingredient, wherein said active ingredient is selected from the group consisting of antibiotic agents, antifungal agents, corticoid, non-steroidal anti-inflammatory agents, and antiviral agents, said ingredient being present in a therapeutically effective amount, and(b) the liquid continuous phase comprises a liquid vehicle comprising a semifluorinated alkane selected from F4H5, F4H6, F6H6 and F6H8;
wherein the composition is substantially free of water, and wherein the particles of the active ingredient have a volume mean diameter as, measured by laser diffraction of not more than about 15 μ
m.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides novel pharmaceutical compositions based on semifluorinated alkanes which are useful as carriers for a broad range of active ingredients. Preferred active ingredients include poorly water-soluble and/or hydrolytically sensitive drug substances. The compositions are designed as suspensions and have superior physical properties which make them highly useful as pharmaceutical delivery systems. The compositions may be administered topically into the eye, or injected via the subcutaneous or intramuscular route. The invention further provides kits comprising such compositions.
78 Citations
20 Claims
-
1. A pharmaceutical composition in the form of a suspension comprising a dispersed phase in a liquid continuous phase wherein:
-
(a) The dispersed phase comprises solid particles of an active ingredient, wherein said active ingredient is selected from the group consisting of antibiotic agents, antifungal agents, corticoid, non-steroidal anti-inflammatory agents, and antiviral agents, said ingredient being present in a therapeutically effective amount, and (b) the liquid continuous phase comprises a liquid vehicle comprising a semifluorinated alkane selected from F4H5, F4H6, F6H6 and F6H8; wherein the composition is substantially free of water, and wherein the particles of the active ingredient have a volume mean diameter as, measured by laser diffraction of not more than about 15 μ
m. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
Specification